Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.
Arthritis Rheumatol. 2017 Feb;69(2):362-375. doi: 10.1002/art.39856.
Arthritis Rheumatol. 2017.
PMID: 27598855
Free PMC article.
Clinical Trial.
Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension Study.
Wallace DJ, Hobbs K, Clowse ME, Petri M, Strand V, Pike M, Merrill JT, Leszczyński P, Neuwelt CM, Jeka S, Houssiau F, Keiserman M, Ordi-Ros J, Bongardt S, Kilgallen B, Galateanu C, Kalunian K, Furie R, Gordon C.
Wallace DJ, et al. Among authors: galateanu c.
Arthritis Care Res (Hoboken). 2016 Apr;68(4):534-43. doi: 10.1002/acr.22694.
Arthritis Care Res (Hoboken). 2016.
PMID: 26316325
Free article.
Clinical Trial.
Item in Clipboard
Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY Trials.
Gottenberg JE, Dörner T, Bootsma H, Devauchelle-Pensec V, Bowman SJ, Mariette X, Bartz H, Oortgiesen M, Shock A, Koetse W, Galateanu C, Bongardt S, Wegener WA, Goldenberg DM, Meno-Tetang G, Kosutic G, Gordon C.
Gottenberg JE, et al. Among authors: galateanu c.
Arthritis Rheumatol. 2018 May;70(5):763-773. doi: 10.1002/art.40425. Epub 2018 Apr 12.
Arthritis Rheumatol. 2018.
PMID: 29381843
Free PMC article.
Item in Clipboard
Limitations of current treatments for systemic lupus erythematosus: a patient and physician survey.
Strand V, Galateanu C, Pushparajah DS, Nikaï E, Sayers J, Wood R, van Vollenhoven RF.
Strand V, et al. Among authors: galateanu c.
Lupus. 2013 Jul;22(8):819-26. doi: 10.1177/0961203313492577.
Lupus. 2013.
PMID: 23817511
Free article.
Item in Clipboard
A Real-World Characterization of Patients With "Moderate-To-Severe" Systemic Lupus Erythematosus.
Strand V, Johnson J, Vandeloo C, Galateanu C, Lobosco S.
Strand V, et al. Among authors: galateanu c.
Value Health. 2014 Nov;17(7):A522. doi: 10.1016/j.jval.2014.08.1634. Epub 2014 Oct 26.
Value Health. 2014.
PMID: 27201636
Free article.
No abstract available.
Item in Clipboard
Effects of Atorvastatin on some inflammatory parameters in severe primary hypercholesterolemia.
Dobreanu M, Gălăţeanu C, Simionescu A, Deac R.
Dobreanu M, et al. Among authors: galateanu c.
Rom J Intern Med. 2002;40(1-4):61-73.
Rom J Intern Med. 2002.
PMID: 15526541
Item in Clipboard
Cite
Cite